Charles River Laboratories International, Inc. (CRL)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 351.85 |
| Open | 349.70 |
| Bid | 354.81 x 800 |
| Ask | 355.26 x 800 |
| Day's Range | 347.14 - 356.34 |
| 52 Week Range | 249.48 - 460.21 |
| Volume | |
| Avg. Volume | 391,836 |
| Market Cap | 17.915B |
| Beta (5Y Monthly) | 1.17 |
| PE Ratio (TTM) | 45.98 |
| EPS (TTM) | 7.72 |
| Earnings Date | Feb. 15, 2022 - Feb. 21, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 443.73 |
- Business Wire
Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
WILMINGTON, Mass., January 11, 2022--Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan and Issues 2022 Financial Guidance
- Business Wire
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
WILMINGTON, Mass., January 06, 2022--Charles River Laboratories to present at J.P. Morgan Healthcare Conference
- Zacks
Here's Why You Should Retain Charles River (CRL) Stock for Now
Investors are optimistic about Charles River (CRL) on acquisitions of Cognate BioServices and Vigene Biosciences.
